NCT06668584 2026-03-04
A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies
M.D. Anderson Cancer Center
Phase 2 Recruiting
Clinical Trials
4 trialsNCT04778410 2025-03-20
Study of Magrolimab Combinations in Participants With Myeloid Malignancies
Gilead Sciences
Phase 2 Terminated
NCT02452697 2024-02-20
NK-DCI
Duke University
Phase 2 Unknown
NCT05807659 2023-04-11
Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies
Sichuan University
Phase 2 Unknown